Elixirr International Plc (ELIX) AI Stock Analysis

• Market Cap: £400.83M
• Dividend Yield: 2.11%
• Average Volume (3M): 101.98K
• Price to Earnings (P/E): 21.3
• Beta (1Y): 0.98
• Revenue Growth: 32.67%
• EPS Growth: -1.61%
• Country: UK
• Employees: 565
• Sector: Industrials
• Sector Strength: 72
• Industry: Consulting Services
• EPS (TTM): 0.29
• Shares Outstanding: 49,615,940
• 10 Day Avg. Volume: 75,512
• 30 Day Avg. Volume: 101,977
• PEG Ratio: -2.62
• Price to Book (P/B): 2.57
• Price to Sales (P/S): 3.04
• P/FCF Ratio: 11.78
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 78 Outperform
• Price Target: 995.00p ▲(17.89% Upside)

Elixirr International Plc's strong financial performance is the most significant factor contributing to its overall stock score. The company's robust revenue growth, efficient operations, and solid cash flow management provide a strong foundation. Technical analysis supports a positive outlook with bullish indicators, while valuation metrics suggest moderate attractiveness. The absence of earnings call and corporate events data does not impact the overall assessment.

Positive Factors

Revenue Growth

Strong revenue growth indicates successful market expansion and effective client engagement, enhancing long-term business prospects.

Balance Sheet Health

A strong balance sheet with low leverage and high equity provides financial stability and flexibility for future growth initiatives.

Cash Flow Management

Efficient cash flow management supports sustainable operations and strategic reinvestment, ensuring long-term financial health.

Negative Factors

EPS Decline

A decline in EPS growth could signal challenges in maintaining profitability, potentially impacting investor confidence and valuation.

Lack of Recent Corporate Events

The lack of recent corporate updates may indicate limited strategic developments, affecting transparency and investor engagement.

Industry Competition

Operating in a highly competitive industry may pressure margins and necessitate continuous innovation to maintain market position.

Elixirr International Plc Business Overview & Revenue Model

Company Description

Elixirr International plc, through its subsidiaries, provides management consultancy services in the United Kingdom, the United States, and internationally. It offers creative, marketing, and self-funded transformation services. The company offers its services for various industries, such as automotive and transportation, manufacturing, business and financial services, charities, energy, utilities and resources, healthcare and pharmaceuticals, insurance, luxury and fashion, travel and leisure, telecommunications, technology, retail and consumer goods, private equity, media, and entertainment and sports industries. Elixirr International plc was founded in 2009 and is headquartered in London, the United Kingdom.

How the Company Makes Money

Elixirr generates revenue primarily through its consulting services, charging clients for project-based work and ongoing advisory services. The company's revenue model is based on fees for consultancy projects, which can vary in complexity and duration. Key revenue streams include management consulting, digital strategy, and operational efficiency projects. Elixirr also benefits from long-term partnerships with various organizations, which can lead to recurring revenue through extended contracts and follow-on work. Additionally, the firm may engage in performance-based contracts where fees are tied to the successful implementation of strategies that drive client growth and efficiency.

Elixirr International Plc Financial Statement Overview

Summary

Elixirr International Plc presents a comprehensive financial profile characterized by strong revenue growth, efficient operations, robust profitability, and solid cash flow management. The company has a sound balance sheet with low leverage and high equity, providing stability and financial flexibility.

Income Statement

Elixirr International Plc has demonstrated robust growth in revenue with a year-over-year increase from 2023 to 2024. The company maintains strong profitability, evidenced by a healthy gross profit margin and net profit margin. The EBIT and EBITDA margins indicate efficient operational management. Overall, the income statement reflects a solid and growing company with strong financial performance.

Balance Sheet

The company's balance sheet is strong, with a low debt-to-equity ratio, reflecting prudent financial management. The equity ratio is high, indicating a stable capital structure with significant stockholders' equity relative to total assets. Return on equity remains attractive, showcasing the company's ability to generate returns for shareholders. The company's financial stability is underscored by its solid asset base and manageable liabilities.

Cash Flow

Elixirr International Plc exhibits impressive cash flow management, highlighted by substantial free cash flow growth. The operating cash flow to net income ratio is strong, indicating efficient conversion of income into cash. Free cash flow to net income is well-aligned, signaling effective reinvestment and financial strategy. The cash flow statements reflect a healthy liquidity position and sound financial practices.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	129.72M	111.34M	85.89M	71.75M	50.61M	30.32M
Gross Profit	41.91M	35.81M	29.26M	23.16M	17.70M	11.19M
EBITDA	31.87M	27.96M	25.78M	20.02M	14.46M	8.97M
Net Income	18.56M	16.38M	17.24M	12.87M	10.14M	4.79M
Balance Sheet
Total Assets	170.17M	175.89M	154.40M	128.66M	107.17M	87.00M
Cash, Cash Equivalents and Short-Term Investments	2.84M	7.53M	18.13M	20.43M	31.80M	17.50M
Total Debt	14.15M	4.90M	5.36M	5.14M	5.25M	5.29M
Total Liabilities	50.06M	43.78M	34.84M	32.74M	21.13M	16.31M
Stockholders Equity	120.12M	132.11M	119.56M	95.92M	86.04M	70.69M
Cash Flow
Free Cash Flow	29.78M	28.76M	16.67M	15.40M	14.23M	12.12M
Operating Cash Flow	29.86M	28.84M	16.79M	15.73M	14.33M	12.15M
Investing Cash Flow	-26.08M	-21.11M	-14.82M	-18.53M	-3.24M	-1.46M
Financing Cash Flow	-23.26M	-18.58M	-4.06M	-8.85M	3.11M	3.88M

Elixirr International Plc Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 844.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ELIX, the sentiment is Positive. The current price of 844 is below the 20-day moving average (MA) of 864.30, above the 50-day MA of 832.22, and above the 200-day MA of 751.03, indicating a neutral trend. The MACD of 1.27 indicates Positive momentum. The RSI at 47.75 is Neutral, neither overbought nor oversold. The STOCH value of 12.92 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:ELIX.

Elixirr International Plc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ELIX	78 Outperform	£400.83M	21.25	15.29%	2.11%	32.67%	-1.61%
GFRD	71 Outperform	£494.47M	14.94	27.48%	3.90%	5.78%	-6.80%
WIL	66 Neutral	£277.62M	24.09	10.14%	3.75%	3.22%	-71.97%
FNTL	65 Neutral	£232.35M	37.48	6.18%	1.69%	23.37%	4.75%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
DATA	56 Neutral	£782.65M	53.28	3.76%	1.24%	9.25%	-51.82%
RWA	55 Neutral	£100.31M	-6.51	-11.22%	12.83%	-14.31%	-361.93%

Elixirr International Plc Corporate Events

Elixirr International Announces Share Purchase by CFO’s Family Member

Elixirr International plc announced a share purchase by Victoria Willott, daughter of CFO Nicholas Willott, who acquired 300 ordinary shares. This transaction increases Nicholas Willott’s beneficial interest to approximately 0.79% of the company’s issued share capital, reflecting ongoing confidence in the company’s market position and growth prospects.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £791.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Elixirr Reports Record Growth and Strategic Expansion in H1 2025

Elixirr International Plc reported a record-breaking first half of 2025, with a 35% increase in revenue compared to the previous year, totaling £71.4 million. The company’s growth was bolstered by a successful transition to the Main Market of the London Stock Exchange and the acquisition of TRC Advisory, a US-based strategy firm. This acquisition, the largest in Elixirr’s history, is expected to enhance its service offerings and market positioning. The company also saw significant growth in its client base, with the number of clients generating over £1 million in revenue increasing from 22 to 31. Elixirr’s strategic focus on expanding its partner team and promoting internal talent has further strengthened its capabilities, positioning the firm for continued success in the consulting industry.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £791.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Elixirr Acquires TRC Advisory to Boost US Presence and Capabilities

Elixirr International Plc has acquired TRC Advisory, LLC, a US-based consultancy specializing in growth strategy and commercial effectiveness, for up to $125 million. This acquisition, which is expected to be immediately earnings-enhancing, marks Elixirr’s largest acquisition to date and aligns with its strategy to expand its capabilities and presence in the US market. The acquisition provides Elixirr with exciting cross-selling opportunities, particularly in industries like manufacturing and industrials where it has less presence, and enhances its service offerings by integrating TRC’s expertise in growth strategy, pricing excellence, and value acceleration.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £791.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Elixirr Expands Debt Facilities to Fuel M&A Strategy

Elixirr International plc has increased its revolving credit facility with National Westminster Bank from £45 million to £65 million and secured an option for a US$20.25 million term loan. This financial move is designed to support the company’s growth strategy, focusing on mergers and acquisitions (M&A) while minimizing equity dilution. The enhanced debt facilities are expected to bolster Elixirr’s ability to pursue strategic acquisitions, thereby strengthening its market position and delivering value to shareholders.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £791.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Elixirr International to Host Live H1 2025 Investor Presentation

Elixirr International plc announced a live investor presentation for its H1 2025 results, scheduled for September 26, 2025. The presentation will feature key executives and is open to current and potential shareholders, allowing for pre-submitted and live questions. This event follows the company’s recent listing on the Main Market of the London Stock Exchange, marking a significant step in its growth and market presence.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £791.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Elixirr International Moves to SETS Ahead of FTSE Small Cap Inclusion

Elixirr International plc has announced the transition of its shares from the SETSqx to the SETS trading platform on the London Stock Exchange, effective 15 September 2025. This move is aimed at increasing liquidity and preparing for the company’s expected inclusion in the FTSE Small Cap Index on 22 September 2025, potentially enhancing its market visibility and attractiveness to investors.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £791.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.